American Association for the Advancement of Science, Science Translational Medicine, 607(13), 2021
DOI: 10.1126/scitranslmed.abd5750
Full text: Unavailable
ATM activation at telomeres confers chemoresistance in ALT neuroblastoma and is reversible in preclinical models by ATM knockdown or inhibition.